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Summary 
Because mice are more resistant than humans to the pathogenic effects of bacterial toxins,  we 
used D-Galactosamine- (D-Gal) sensitized mice as a modal system to evaluate potential toxic shock 
symptoms triggered by the superantigcn staphylococcal  enterotoxin B (SEB). We show that similar 
to endotoxin (lipopolysaccharide) [LPS], the exotoxin  SEB causes lethal shock within 8 h in 
D-Gal-sensitized mice, inducing 100% and about 50% lethality with 20 and 2 ~g SEB, respectively. 
The lethal shock triggered by the superantigcn  SEB is mediated by T cells, a conclusion based 
on the observation  that T cell repopulation of SCID mice conferred sensitivity to SEB. Since 
CSA also conferred protection, the role of T ceU-derived lymphokines in mediating lethal shock 
was evaluated. Within 30-60 min after SEB injection, serum tumor necrosis factor (TNF) levels 
peaked, followed immediately by interleukin-2 (IL-2). Serum-borne lymphokines were detected 
weU in advance of signs of T ceU activation, as assessed  by IL-2 receptor expression of SEB-reactive 
VB8 + T ceUs. Passive immunization with anti-TNF-a/~-neutralizing monodonal antibody also 
conferred protection, indicating that it is TNF which is critical for initiating toxic shock symptoms. 
Taken together, this study defines basic differences between endotoxin (LPS)- and cxotoxin (SEB)- 
mediated lethal shock, in that the former is mediated by macrophages and the latter by T calls. 
Yet the pathogcnesis distal to the lymphokine/cytokine-producing  cells appears surprisingly similar 
in that TNF represents  a key mediator in inducing shock. 
B 
acterial endotoxins are recognized as a major factor in 
the pathogenesis of Gram-negative  septic shock, a dis- 
ease with significant morbidity and mortality in humans (1, 
2). Macrophages  appear to be essential in mediating endo- 
toxin reactions, since adoptive transfer of endotoxin-sensitive 
macrophages renders previous endotoxin-resistant  mice sen- 
sitive to endotoxin (3). Further, it has been established that 
the macrophage product TNF-odcachectin is central in causing 
endotoxin lethality, a cytokine produced by macrophages in 
response to endotoxins (4). 
Not only endotoxins, but also bacterial exotoxins from cer- 
tain Gram-positive bacteria cause toxic shock in humans (5-7). 
Whereas the mechanisms of endotoxin-induced shock became 
increasingly defined (3, 4), the mode of action of bacterial 
exotoxins is unclear as yet. A clue might represent the recent 
demonstration that some of these exotoxins exhibit the un- 
usual properties of superantigens thereby stimulating in vitro 
and in vivo massive T cell proliferation (8, 9). Superantigens 
have been operationally  defined as bifunctional molecules 
binding to MHC class II structures  and activating  T  cells 
expressing appropriate  V~ segments of the TCR (9-12). 
The ability of exotoxins to act as superantigens for T cells 
represents a logical starting point to hypothesize that exotoxin- 
mediated rapid  T  call activation  leading to systemic lym- 
phokine secretion may be causally linked to the pathogenesis 
of shock. Indeed T cell-derived lymphokines appear to cause 
shock-like syndromes as deduced from observations in human 
after  therapeutic  anti-CD3  mAb  application  in  allograft 
recipients  (13, 14). 
Here,  we  have  studied  the  pathogenic  effects of one 
staphylococcal toxin, enterotoxin B (SEB)  1 in mice. To by- 
pass the known natural resistance of mice to the effects of 
bacterial toxins (8), we increased their sensitivity by pretreat- 
1  Abbreviations used in this paper'. CSA, Cyclosporin A; v-Gal, D-Galactos- 
amine; SEB, staphylococcal enterotoxin B; TSS, toxic shock syndrome; 
TSST-1, toxic shock syndrome toxin 1. 
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port  that  in  D-Gal-sensitized  mice  the  superantigen  SEB 
triggers  a  T  cell-mediated  lethal  shock  syndrome. 
Table  1.  Lethal Effect of SEB (or LPS) in n-GAL-sensitized 
Mice 
Materials  and  Methods  o-Gal 
Mice and Culture Medium.  Mice of the strain BALB/c (H-2a), 
C3H/He (H-2k),  and C57BL/6 (H-2  b) were purchased from the  mg 
Zentralinstitut ffir Versuchstierzucht, Hannover, Germany. SCID  20 
mice were obtained from the Geseilschaft ftir Strahlen- und Um-  40 
weltforschung  (Munich,  Germany).  The  medium  used  was 
Click/RPMI 1640 (Biochrom, Berlin, Germany) supplemented with 
10% (vol/vol) FCS,  10 mM Hepes buffer,  5  x  10 -s 2-ME, 1/zg/ 
ml indomethacin,  and antibiotics,  respectively. 
mAb and Reagents.  Hybridoma  F23.1  (producing  anti-V38 
mAb) was kindly provided by Dr. M. Bevan (Scripps Institute, La  20 
Jolla, CA). The supernatant of this hybridoma was purified using  20 
a protein G column (Pharmacia, Freiburg, Germany). Hybridoma  20 
7D4 producing a mAb reactive with the murine IL2R was ob- 
tained from American Tissue Culture Collection (Rockville, MD).  20 
The mAb was purified from ascites fluid and FITC labeled according 
to the method of Goding (17). Anti-V38 mAb was labeled with 
biotin (17). The mAb Vlq neutralizing murine TNF-cr  and TNF-3 
has been described recently (18). 
The exotoxin SEB ($4881), the endotoxin LPS (L3129), and MTT 
(M2128)  were purchased from Sigma, Munich,  Germany. D-Gal  20 
hydrochloride (7411) was from Roth, Karlsmhe, Germany. Recom-  20 
binant human IL-2 (batch no. LP-3170B) was a kind gift from Eu-  20 
rocetus, Amsterdam, The Netherlands. Cyclosporin A (CSA) was 
generously provided by Dr. Borel, Sandoz AG, Basel, Switzerland. 
FACS |  Analyses.  The draining, popliteal lymphnodes were re- 
moved and a single cell suspension was prepared. Thereafter, cells 
were stained on ice with FITC labeled anti-Ib2R and PE-conjugated 
anti-V38  mAb, respectively,  washed twice with PBS containing 
2% FCS, and subsequently fixed with 1% paraformaldehyde. The 
labeled cells were analyzed on a Elite flow cytometer (Coulter Elec- 
tronics Inc., Hialeah,  FL).  ~  5 
Preparation of Serum.  Immunized  and  control  animals were  ~  ~  4 
killed,  and blood was drawn  from the heart.  Subsequently,  the  ~ -:  m  3 
samples were centrifuged at 10,000 rpm, the supernatant collected  .~,  . 
"  .'-  2  and stored at  - 70~  until used in the Ib2 and TNF assay, respec-  ~ 
tively.  ~  1 
TNFAssay.  TNF levels in mouse serum were determined using  ~  0 
TNF ELISA kits (Genzyme Corp., Cambridge, MA). The assay 
was performed exactly as described by the manufacturer.  Serum 
samples were used at a dilution of 1:5. Each sample was determined 
in triplicate. 
Assay for IL2 Activity.  To measure IL-2 levels, the CTLL bio- 
assay was performed as described  (19). Briefly, 1.5  x  104 cells/well  5 
were incubated with serum samples, diluted 1:100 for 24 h. MTT,  -~  4 
which was metabolized by living cells in 2 h, was then added. After  ~.~  3 
solubilization of MTT crystals with isopropanol, the OD was de-  ~ 
termined at 570 nm. To express the Ib2 activity in serum samples  ~  2 
in U/ml,  a standard curve was established by incubating CTLL  ~ ~ 
cells with different amounts of recombinant human (rhu) Ib2. Each  ~  o 
serum sample was measured in triplicate. 
Results 
Lethal Effect of SEB in n-Galactosamine-treated  Mice.  The 
lethal toxicity of SEB was evaluated in D-Gal-sensitized mice, 
and compared with that of LPS. Groups of mice received a 
Treatment  Lethality 
within  8 h 
SEB  LPS  (dead/total) 
/z  g /mouse  /z  g 
-  0/3" 
-  -  0/3" 
300  :-  0/3" 
200  -  0/3" 
20  -  0/3* 
200  -  4/4 
20  -  4/4 
2  -  1/4 
0.2  -  0/4 
-  100  0/3 
-  50  0/3 
-  5  0/3 
-  10  3/3 
1  3/3 
-  0.1  1/3 
Groups of BALB/c mice simultaneously received D-Gal intraperitoneal 
and SEB (hind footpads), or D-Gal and LPS (intraperitoneal), respective- 
ly. Controls  received n-Gal, SEB, or LPS alone. 
* No apparent signs of illness. 
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Figure  1.  Groups of BALB/c mice (four/group) were simultaneously 
treated with 20 mg D-Gal  (i.p.) and titrated amounts of SEB (hind footpads) 
as indicated. 
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enhance sensitivity to LPS (15), and in addition, SEB or LPS. 
Animals receiving D-Gal, SEB, or LPS alone served as con- 
trols. In accordance with published data (15) Table 1 shows 
that D-Gal treatment confers high sensitivity to LPS. For ex- 
ample, 1 #g LPS was lethal in D-Gal-sensitized BALB/c mice, 
while in unsensitized mice 100 #g caused only marginal signs 
of illness such as immobility and rough fur, but no lethality. 
As in the case of LPS, none of the unsensitized BALB/c mice 
died upon injection of up to 300 #g SEB. At these high doses 
the animals  showed marginal  signs  of illness  (immobility, 
rough fur), but recovered within 24-48 h.  However, upon 
D-Gal sensitization 20 #g SEB suf~ced to cause death in all 
injected mice (Table 1). There was no significant difference 
in toxicity between SEB, given intraperitoneal,  intravenous, 
or subcutaneously (data not shown). In addition, D-Gal-sen- 
sitized C3H and C57BL/6 mice behaved almost identically 
to BALB/c mice in their  shock response to SEB (data not 
shown). 
The time course of lethality induced by LPS or SEB in 
D-Gal-sensitized mice was ,,o8 h.  The first signs of illness 
(immobility,  rough  fur)  became  apparent  *3-4  h  before 
death. Only when sublethal doses of SEB were administered 
did D-Gal-sensitized mice survive up to 48 h. Thereafter,  some 
of the animals recovered again (Fig. 1). As reported for endo- 
toxin lethality in D-Gal-sensitized animals (15), D-Gal-medi- 
ated sensitization to SEB was most effective when D-Gal and 
SEB were injected with a time interval of less than 2 h. When 
D-Gal was administered 4 h before SEB, or 4-6 h after SEB, 
lethality was not observed (data not given). The lethal tox- 
icity of SEB in D-Gat-sensitized mice was seen in many dupli- 
cate experiments with some variations in the effects of a par- 
ticular dose of toxin. We conclude that similar to endotoxin 
(15), D-Gal renders mice susceptible to lethal shock triggered 
by the exotoxin SEB. 
T Cell Requirement  for the Lethal Toxicity of SEB,  It has 
been established that SEB acts as a superantigen for T  cells 
expressing appropriate V~ chains of the TCR (10).  There- 
fore we evaluated the requirement for T cells to cause lethal 
toxicity. In the first approach, we functionally depleted mice 
for T  cells by administering  CSA, a reagent known to sup- 
press lymphokine secretion by T  cells (20). All CSA-treated 
and D-Gal-sensitized mice survived without signs of illness 
when challenged with an otherwise lethal concentration of 
SEB (Table 2). These data indicated that the release of lyrn- 
phokines from SEB-reactive T  cells may be central for the 
lethal  shock. 
In the second approach, SCID mice known to lack T and 
B cells,  were used.  As shown in Table 2, D-Gal-sensitized 
SCID mice were sensitive to LPS, indicating that their mac- 
rophage reactivity to LPS was sufficient to cause endotoxin- 
mediated lethal shock.  Table 2 also shows that SCID mice 
treated with D-Gal were resistant to the lethal toxicity of SEB, 
indicating that T  cells are required for the manifestation of 
toxicity. This was confirmed by the observation that upon 
reconstitution  of  SCID  mice  with  T  cells  (15  x  10  6 
cells/mouse), administration of SEB caused lethal shock. We 
Table  2.  T Cell-mediated Lethal Shock Syndrome 
n-Gal  CSA  SEB  LPS 
(20 mg  (0.5 mg  (20 #g/  (10 #g 
i.p.)  i.p.)  mouse)  i.p.) 
Letha~ty 
(dead/total) 
BALB/c  SCID 
-  -  +  -  0/3  ND 
+  -  +  -  3/3  0/9 
+  +  +  -  0/5  ND 
+  -  +  -  3/3  5/5* 
+  -  -  +  3/3  3/3 
Treatment of mice with more than one agent was done at the same time 
with doses indicated in the table. 
* SCID mice were reconstituted with 15 x  10  s BALB/c T calls 6 d be- 
fore injection. 
concluded that T cells are mediating the lethal toxicity trig- 
gered by SEB. 
Kinetics of Lymphokine Release and T  Cell Activation in n- 
Gal-treated Mica  The acute (within 8 h) T  cell-mediated 
lethal  toxicity triggered  by SEB in  D-Gal-sensitized  mice 
prompted us to evaluate signs for T  cell activation in LNs 
draining the site of SEB injection. Since V/38-expressing T 
cells are known to respond to SEB (12), we scored over time 
by two-color staining  the appearance  of IL-2K + V/$8 + T 
cells in LNs draining the side of SEB injection. Representa- 
tive data as demonstrated in Fig. 2 show that 8 h after SEB 
administration  all V~8 + T  cells within the draining LN be- 
came IL-2K +.  A  timing  of IL-2R expression revealed  that 
2-4  h  after SEB application  V~8 + became IL-2R +.  After 
8 h virtually all VB8 + T  cells expressed the IL-2K at high 
densities (mean fluorescence intensity is recorded in channel 
8,  Figs.  2  and 3 A).  In other words,  Ib2K expression in 
vivo tags the subset of T  cells  reactive to SEB.  Note that 
IL-2R expression of V/~8 + T  cells was equally independent 
whether mice were D-Gal  sensitized or not  (Fig.  3 A). 
Because the protective effect of CSA (Table 2) suggested 
that release of lymphokines was central to the lethal toxicity 
triggered by SEB, we next evaluated 11.-2 and TNF lymphokine 
levels in the blood of D-Gal-sensitized or unsensitized mice 
treated with SEB. Surprisingly,  as early as 1-2 h upon SEB 
injection, peak levels of II.-2 were present in the blood (Fig. 
3 B). Thereafter, blood-borne IL-2 concentrations sharply de- 
creased both in D-Gal-sensitized and unsensitized mice. Peak 
levels of TNF were detected as early as 30-60 rain upon SEB 
administration (Fig. 3 A). Again, TNF levels decreased sharply 
at later time points. We conclude that SEB-triggered release 
of lymphokines from T cells represents an immediate event, 
well in advance of SEB-mediated triggering  of proliferative 
responses of SEB-reactive T  cells,  as defined by IL-2K ex- 
pression. 
Anti-TNF-o./~ mAb Confer Protection.  There is compel- 
ling evidence that the lethal effects of endotoxin during sep- 
ticemia can be prevented by passive immunization  of mice 
93  Miethke  et al. Figure 2.  T cells of the draining  popliteal  lymph  node were stained  with FITC-labeled  anti-IL-2R  mAb and biotin/PE-labeled  anti-V/~8 mAb. In 
A and B, Balb/c mice were treated with SEB (20/~g/footpad)  alone, while  in C and D, mice received  D-Gal (20 mg i.p.) and SEB (20/~g/footpad). 
A and C depict cells 2 h, and B and D 8 h after treatment. 
against TNF-cffcachectin (4). Because of the apparent similar- 
ities between LPS- and SEB-triggered lethal shock in n-Gal- 
sensitized mice (Tables 1 and 2),  we speculated whether T 
cell-dependent lymphokines such as TNF-a/cachectin and/or 
TNFo~/lymphotoxin might represent key mediators for the 
T-cell-mediated lethal shock induced by SEB. We therefore 
used the neutralizing anti-mouse TNF mAb Vlq,  shown 
to protect mice from LPS-induced shock as well has to neu- 
tralize the T cell lymphokine TNF-B/lymphotoxin (18), to 
evaluate for its protective effects. As shown in Table 3, pas- 
sive immunization with Vlq mAb also conferred protection 
against the lethal effect of SEB as well as that of LPS. In fact, 
amounts ofmAb Vlq as low as 50/zg/mouse were effective. 
We conclude that TNF plays a critical role in inducing lethal 
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Figure 3.  A shows the kinetic of the expression of the IL-2K on Vfl8 + 
T cells of the draining popliteal lymph node. BALB/c mice were treated 
with either SEB alone (20 pg/footpad, filled circles), or with v-Gal (20 
mg i.p.) and SEB (20 #g/footpad, open triangles). Each symbol represents 
three individual mice. B depicts the kinetic of serum levels of I1.-2 in mice 
injected with SEB alone (20 #g/footpad, filled circles) or with v-Gal (20 
mg i.p.) and SEB (20 #g/footpad, open triangles). Each symbol represents 
three individual mice.  IL-2 was measured using the CTLL bioassay. In 
C, the kinetic of TNF serum levels is demonstrated. At each time point 
the sera of two individual mice treated with 20 #g SEB and 20 mg v-Gal 
(open triangles), or 20 #g SEB alone (closed circles) were analyzed.  TNF 
was measured with commercially available ELISA kits as described in Ma- 
terial and Methods. 
toxicity in the exotoxin shock studied here. Yet the lack of 
specific mAb discriminating  between TNF-ol and TNF-fl hin- 
dered our identification of the type of TNF involved. 
Table  3.  Anti-TNF  mAb  Confers Protection 
Anti-TNF 
D-Gal  SEB  mAb Vlq  Lethality 
(20 mg i.p.)  (20  #g/mouse)  /zg i.p.  (dead/total) 
+  +  250  0/2 
+  +  50  0/2 
+  +  10  2/3 
+  +  1  3/3 
Groups of BALB/c mice were injected with D-Gal and SEB at the same 
time. 2 h in advance titrated amounts of anti-TNF mAb Vlq were ad- 
ministered. Isotype-matched control mAb were without effects (data not 
shown). 
Discussion 
Exotoxins of certain Gram-positive bacteria are known to 
contribute to toxic shock pathogenesis and to function as 
superantigens as well (10, 21). Whether both facets are caus- 
ally linked is at present unknown. Probably because mice are 
relatively resistant to bacterial  toxins, use of murine animal 
models in studying pathogenesis of exotoxin-induced toxic 
shock has been limited (22). The sensitivity of mice to endo- 
toxin can be greatly enhanced by impairing liver metabolism 
with D-Gal (15). Here we adopted this approach to evaluate 
the pathogenesis of exotoxin-mediated toxicity. We show that 
upon D-Gal sensitization of mice the superantigen SEB causes 
lethal toxicity within 8 h, while D-Gal-sensitized SCID mice 
become sensitive to SEB only upon repopulation with T cells. 
Manifestation of lethal toxicity requires SEB-reactive VB8 + 
T cells, and is inhibited by CSA, a reagent known to block 
production of lymphokines by T  cells. Within 30-60 rain 
upon SEB administration, high concentrations of TNF and, 
within 1-2 h, high concentrations of II.-2 are noted in the 
blood. In contrast to the immediate lymphokine  release into 
the blood, activation of VB8 + T  cells by SEB in terms of 
I1.2K expression,  an early marker for T  cell activation, re- 
quires 4-8 h. Passive immunization of mice with TNF-cd/~ 
neutralizing mAb Vlq effectively conferred resistance to T 
cell-mediated shock. We conclude that D-gal-induced sen- 
sitization of mice represents a useful model system in un- 
raveling  not only the central role of T  cells, but also that 
of T cell-dependent TNF in the pathogenesis of the lethal 
shock triggered by the exotoxin SEB. 
The TSS-toxin 1 produced by toxigenic strains of Staphy- 
lococcus aureus (21, 23) is probably the best documented ex- 
ample of an exotoxin causing TSS in humans. While TSST-1 
has no direct toxic effect on a variety of tissues tested (24), 
it represents a powerful in vitro activator of lymphocytes and 
monocytes thereby inducing the production of many T cell 
lymphokines including IL,2 (25), IFN-3', TNF-/~-lymphotoxin 
(26), and colony stimulating factors (27), as well as cytokines 
such as I1-1 and TNF-o#cachectin (28, 29). Since the symp- 
toms observed in patients suffering from TSS are similar in 
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tration of large quantities of I1:2 during human cancer therapy 
(30) or anti-CD3 mAb administration to transplant recipients 
(13, 14), we searched for a useful in vivo model for dissecting 
the pathogenesis of shock symptoms as triggered by super- 
antigenic bacterial  exotoxins. 
Because mice are more resistant  to bacterial  toxins than 
are humans, high doses of the toxin SEB, for example, are 
needed to observe T cell-mediated stress symptoms such as 
weight loss and thymic involution (22, own observations). 
Since in humans acute toxic shock reactions dominate the 
response of mice to superantigenic exotoxins (21, 23),  we 
searched for means to enhance the sensitivity of mice to su- 
perantigenic exotoxins. To this we evaluated the effect of D-Gal 
(2-amino-2-deoxy-D-galactose), a substance known to increase 
the sensitivity of mice to the lethal effects of endotoxin (15, 
16) severalfold. D-Gal is a hepatotoxic agent, and the devel- 
opment of sensitization to endotoxin requires depletion of 
UTP and changes in uracyl nudeotides thereby impairing 
biosynthesis of macromolecular cell constituents (3). 
In both D-Gal-treated  and untreated mice there was no 
obvious difference in the kinetics of appearance of serum-borne 
TNF and I1:2, and the kinetics of I1:2R expression within 
SEB-reactive V/~8  + T cells (Fig. 3, B and C). However, only 
the former succumbed to lethal shock (Tables 1 and 2,  see 
below). We take this as argument that the effect of D-Gal 
is only to augment sensitivity to endogeneous mediators (15), 
rather than to affect their rate of production. 
As in the case of LPS (reference 15, Table 1), we show here 
(Table 1) that SEB is highly toxic in D-Gal-sensitized  mice, 
inducing 100 and 50% lethality with 20 and 2 #g SEB, respec- 
tively. In the absence of I)-Gal, up to 300/zg SEB caused 
no lethality (Table 1). As in the case of LPS (15), the state 
of I~-Gal-induced  hypersensitivity to SEB lasts only about 
4-6 h, and mice sensitized with D-Gal and a lethal dose of 
SEB developed the first signs of illness about 4 h before death, 
which took place 6-8 h upon injection. 
In contrast to endotoxin (LPS), the exotoxin SEB caused 
no lethal toxicity in r~-Gal-sensitized SCID mice known to 
lack B and T cells. Yet adoptive transfer oft cells into SCID 
mice conferred sensitivity to the lethal effect of SEB (Table 
2). In addition, the compound CSA, known to inhibit lym- 
phokine production by T  cells (20),  effectively protected 
D-Gal-sensitized mice towards SEB-induced toxicity. It follows 
that upon D-Gal application mice developed sensitivity to le- 
thal shock induced not only by LPS but also by SEB. How- 
ever, the basic difference between both toxins is that macro- 
phages are mediating the endotoxin reactions (3) while the 
lethal shock triggered by the superantigen, i.e., exotoxin SEB, 
are mediated by SEB-reactive T  cells. 
In Gram-negative septicemia, the macrophage product 
TNF-odcachectin appears early in circulation as a brief peak 
upon infusion of bacterial LPS (31), but is sufficient to in- 
duce secondary cytokines including 11:1 and I1:6 (32). Fur- 
ther, upon infusion of high doses of TNF-odcachectin in 
experimental animals, toxic shock symptoms such as cardio- 
vascular collapse, lactic acidosis, and extravascular fluid se- 
questration ensue (31). Because T cells are mediating SEB- 
induced lethal shock, we considered T cell-dependent TNF- 
a~ cachectin (33) or TNF-fl/lymphotoxin (33) as prime can- 
didates in effecting lethal shock. This conclusion is supported 
by our finding that passive immunization with anti-TNF mAb 
neutralizing both TNF-a/cachectin and TNF-~/lymphotoxin 
(18) effectively conferred resistance to SEB-triggered T cell- 
mediated shock (Table 3). These results define TNF as a key 
mediator not only in endotoxin/macrophage-mediated  lethal 
shock (34) but also in T cell-dependent shock. TNF-o~ and 
TNF-~ can be produced by T cells (33), and are lymphokines 
with limited-sequence homology, (35) but bind the same 
receptors (31, 36) and have common effects on a large number 
of target cells (31, 36).  Excessive production of TNF-oe or 
TNF-/5 might therefore yield in similar toxic symptoms, a 
conclusion supported by our observation that endotoxin/TNF- 
or-mediated lethal shock symptoms are phenotypically in- 
distinguishable from the lethal shock induced by the exotoxin 
SEB. 
The kinetics of production and elimination of serum-borne 
TNF and I1:2 during SEB-induced shock and its relation to 
I1:2R expression in SEB-reactive V~8 + T cells were unex- 
pected. Within 30-60 min upon SEB injection, serum-borne 
TNF peaked, followed 60 rain later with a peak of I1:2. Both 
mediators declined thereafter, as if an SEB-induced immediate 
burst of T cell-dependent mediators were followed by a phase 
of elimination from circulation at a constant rate.  On the 
other hand, there was a clear delay in time until SEB-reactive 
T cells became I1:2R +, an early marker for T cell prolifera- 
tion. It thus appears that T cell-dependent mediators such 
as TNF trigger toxic shock symptoms well in advance of 
the  signal  events  yielding  in  cellular  activation  of  the 
lymphokine-secreting T  cells (Fig.  2). 
In contrast to the marked lethality associated with TNF-a 
in endotoxin-mediated septic shock (37), TNF-a is tolerated 
when administered to humans in clinical trials  (38).  Since 
in mice the lethal effect of TNF-a is potentiated by I1-1 (39) 
and fatal outcome in human septic shock is associated with 
high levels of not only TNF, but also I1:6 and II:1, (32) the 
role of additional cytokines such as II:1 and I1:6 in SEB- 
mediated shock needs now to be evaluated. 
In conclusion, our study demonstrates the applicability of 
I)-Gal-sensitized  mice in studying the pathogenesis of bac- 
terial exotoxin-mediated lethal shock. In this system, exotoxin- 
reactive T cells cause shock via systemic and immediate re- 
lease of lymphokines. Since passive immunization with neu- 
tralizing anti-TNF-oe/~ mAb confers protection, T cell-de- 
pendent TNF appears to play a principal role. Thus, exotoxin 
and endotoxin shock seem to differ in the sense that T cells 
are mediating the former and macrophages the latter,  but 
the events distal to the mediator-producing cells might be 
very similar in that TNF is central in causing toxicity. 
96  T Cell-mediated Shock Syndrome This work was supported by the Sonderforschungsbereich (SFB) 322 and the Bundesministerium ffir 
Forschung und Technologic (BMFT). 
Address correspondence  to H. Wagner, Institute of Med. Microbiology  and Hygiene, Techn, Univ. Munich, 
Trogerstr. 9, 800 M~inchen 80, Germany. 
Received for publication  9 August  1991 and in revised form 26 September  1991. 
References 
1.  Morrison, D.C., andJ.L. Ryan. 1987. Endotoxins and disease 
mechanisms. Annu. Rev. Med. 38:417. 
2.  Wolff, S.M., and J.V. Benett. 1974. Gram negative rod bacter- 
aemia (editorial). N. Engl. J. Med. 291:733. 
3.  Freudenberg, M.A., D. Keppler, and C. Galanos. 1986. Re- 
quirement for lipopolysaccharide-responsive  macrophages in 
galactosamineqnduced  sensitization  to endotoxin. Infect. Iraraun. 
51:891. 
4.  Tracey,  K.J., Y. Fong, D.G. Hesse, K.R. Manogue, A,T. Lee, 
G.C. Kuo, S.F. Lowry, and A. Cerami. 1987. Anti-cachectin/ 
TNF monodonal antibodies prevent septic shock during le- 
thal bacteraemia. Nature (Lond.). 330:662. 
5.  Bergdoll, M.S. 1979. Staphylococcal intoxications. In Food 
Bourne Infections and Intoxications, H, Riemann, and F.L. 
Bryon, editors. Academic Press, New York. 443-494. 
6.  Schlievert, P.M., K.N. Shands, B.B. Dan,  G.P. Schmid, and 
R.D. Nishimura. 1981. Identification and characterization of 
an exotoxin from Staphylococcus aureus associated with toxic 
shock syndrome. J. Infect. l~'s. 143:509. 
7.  Spero, L., A. Jonson-Winger, and JJ.  Schmidt.  1988. En- 
terotoxins of Staphylococci.  In Handbook of Natural Toxins. 
C.M.  Hardgree, and A.T. Tu, editors, Marcel Dekker, Inc., 
New York. 131-163. 
8.  Peary, D.L., W.H. Adler, and R.T. Smith. 1970. The mito- 
genic effects of endotoxin and Staphylococcal  enterotoxin B 
on mouse spleen cells and human peripheral lymphocytes.  J. 
Immunol. 105:1453. 
9. Janeway, C.A., Jr., J. Yagi, P.J. Conrad, M.E. Katz, B. Jones, 
S. Vroegop, and S. Buxser. 1989. T-cell responses to Mls and 
to bacterial proteins that mimic its behavior. Immunol. Rev. 
107:61. 
10.  Marrack, P.,  and J.  Kappler. 1990. The staphylococcal en- 
terotoxins and their relatives. Science (Wash. DC). 248:705. 
11.  Fleischer,  B., and H. Schrezenmeier. 1988. T cell stimulation 
by staphylococcal  enterotoxins. Clonally variable response and 
requirement for major histocompatibility  complex  class II mol- 
ecules on accessory or target cells.  J. Ext~ Med. 167:1697. 
12.  White, J., A. Herman, A.M. Pullen, K. Kubo, J.W. Kappler, 
and  P.  Marrack. 1989. The  V  beta-specific superantigen 
staphylococcal enterotoxin B: stimulation of mature T cells 
and donal deletion in neonatal mice. Cell. 56:27. 
13.  Cosimir, A.B., R.B. Colvin, R.C. Burton, R.H. Rubin, G. 
Goldstein, PC.  Krug,  P.  Hansen, F.L. Delminco, and P.S. 
Russel. 1981. Use of monoclonal antibodies to T cell subsets 
for immunologic monitoring and treatment in recipients of 
renal allografts. N. Engl. J. Med. 305:308. 
14.  Chatenoud, L., C. Ferran, A. Reuter, C. Legendre,  Y. Gevaert, 
H. Kreis, P. Franchimont, andJ.F. Bach. 1989. Systemic  reac- 
tion to the anti-T-ceU monoclonal antibody OKT3 in relation 
to serum levels of tumor necrosis factor and interferon-gamma. 
97  Miethke  et al. 
N. Engl, J. Med. 320:1420. 
15.  Galanos, C.,  M.A.  Freudenberg, and  W,  Reutter.  1979. 
Galactosmine-induced  sensitization of the lethal effects of en- 
dotoxin. Proc Natl. Acad. Sci, USA.  76:5939. 
16.  Lehmann, V., M.A. Freudenberg, and G. Galanos. 1987. Le- 
thal toxicity of lipopolysaccharide  and tumor necrosis factor 
in normal and D-galactosamine-treated mice. J. Ex  v  Med. 
165:657. 
17.  Goding, J.W. 1986. Immunofluorescence.  In Monoclonal An- 
tibodies: Principles and Practice. Harcourt Brace Jovanovich 
Publications, New York. 255-265. 
18.  Echtenacher, B., W. Falk, D.N. Mannel, and P.H. Krammer. 
1990. Requirement  of endogenous tumor necrosis factor/ 
cachectin for recovery  from experimental  peritonitis.J, lmmunoL 
145:3762. 
19,  Heeg,  K.,J. Reimann, D. Kabelitz, C. Hardt, andH. Wagner. 
1985. A rapid colorimetric assay  for the determination of I1r 
producing helper T cell  frequencies.J.  Iramunol. Methods. 77:237. 
20.  Bunjes, D., C. Hardt, M. R611inghoff,  and H. Wagner. 1981. 
Cyclosporin A mediates immunosuppression of  primary cyto- 
toxic T lymphocytes by impairment release of interleukin I 
and interleukin 2. Eur. J. lramunol. 11:657. 
21.  Crass, B.A., and M.S. Bergdoll. 1986. Toxin involvement in 
toxic shock syndrome. J. Infect. Dis. 153:918. 
22.  Marrack, P., M. Blackman, E. Kushnir, and J. Kappler. 1990. 
The toxicity of staphylococcal  enterotoxin B in mice is medi- 
ated by T cells.  J. EXla Med. 171:455, 
23.  Bergdoll, M.S., B.A. Crass, R.F. Reiser, K.N. Robbins, and 
J.p. Davies. 1981. A new staphylococcal  enterotoxin,  enterotoxin 
F, associated  with toxic shock syndrome staphylococcal  aureus 
isolates. Lancet. i:1017. 
24.  Parsonnet,  J. 1989. Mediators  in the pathogenesis  of  toxic shock 
syndrome: overview. Rev. Infect. Dis. 11(Suppl 1):$263. 
25.  Uchiyama, T.,  Y.  Kamagata, M.  Wakai, M,  Yoshioka, H. 
Fujikawa, and H. Igarashi. 1986. Study of the biological ac- 
tivities of toxic shock syndrome toxin-1. I. Proliferative re- 
sponse and interleukin 2 production by T cells stimulated with 
the toxin. Microbiol. Immunol. 30:469. 
26. Jupin, C., S. Anderson, C. Damais,  J.E. Alouf, and M. Parant. 
1988. Toxic shock syndrome toxin 1 as an inducer of human 
tumor necrosis factor and 3' interferon.J. ExF Med. 167:752. 
27.  Galelli, A., S. Anderson, B. Chariot,  and J.E.  Alouf. 1989. 
Induction of  murine hemopoietic  growth factors  by toxic shock 
syndrome toxin-1, j. ImmunoL 142:2855. 
28.  Ikejima, T., C.A. Dinarello, D.M. Gill, and S.M. Wolff. 1984. 
Induction of human interleukin-1 by a product of Staphylo- 
coccus aureus associated with toxic shock syndrome. J. Clin 
Invest. 73:1312. 
29.  Fast, D.J., P.M. Schlievert, and R.D. Nelson. 1989. Toxic  shock 
syndrome-associated  staphylococcal  and streptococcal  pyrogenic toxins are potent inducers of tumor necrosis factor produc- 
tion. Infect. Immun. 57:291. 
30.  Kosenberg, S.A., M.T. Lotze, andJ.J. Mule. 1988. NIH con- 
ference. New approaches to the immunotherapy of  cancer using 
inter|eukin-2.  Ann. Intern. Ailed. 108:853. 
31.  Beutler, B., and A. Cerami. 1989. The biology of cachectin/ 
TNFqa primary mediator of the host response. Annu. Rev. 
Immunol. 7:625. 
32.  Waage, A., P. Brandtzaeg, A. Halstensen, P. Kierulf, and T. 
Espevik. 1989. The complex pattern of  cytokines  in serum from 
patients with meningococcal  septic shock. Association  between 
Interleukin 6, Interleukin 1, and Fatal Outcome.J. Extz Med. 
169:333. 
33.  Cuturi, M.C., M. Murphy, M.P. Costa-Giomi, K. Weinmann, 
B. Perussia, and G. Trinchieri. 1987. Independent regulation 
of  tumor necrosis  factor and lymphoto:dn l:rtoduction  by human 
peripheral blood lymphocytes. J. Exl~ Med. I65:1581. 
34.  Beutler, B., I.W. Milsark, and A.C. Cerami. 1985. Passive  im- 
munization  against cachectin/tumor necrosis factor protects 
mice from lethal  effect of endotoxin.  Science (Wash. DC). 
229:869. 
35.  Gardner, S.M., B.A. Mock, J. Hilgers, K.E. Huppi, and W.D. 
ILoeder. 1987. Mouse lymphotoxin and tumor necrosis factor: 
structural analysis of the cloned genes, physical linkage, and 
chromosomal position. J. Immunol. 139:476. 
36.  Paul, N.L., and N.H. Rnddh. 1988. Lymphotoxin. Annu. Rev. 
Imraunol. 6:407. 
37.  Waage, A., A. Halstensen, and T. Espevik. 1987. Association 
between turnout necrosis factor in serum and fatal outcome 
in patients with meningococcal disease. Lancet. i:355. 
38.  Gramm,  H., A. Lindenman,  R. Mertelsmann,  and F. Her- 
mann. 1991. Phase I trial of  rec. human TNFcx in patients with 
advanced malignancy. Eur.  J. Canc~  In press. 
39.  Waage, A., and T. Espevik. 1988. Interleukin  1 potentiates 
the lethal effect of tumor necrosis factor r  in mice. 
J. Exp. Med. 167:1987. 
98  T Cell-mediated Shock Syndrome 